{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T07:16:30Z","timestamp":1768115790808,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.urology.2022.04.026","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T11:10:09Z","timestamp":1651835409000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2486-1601","authenticated-orcid":false,"given":"Miyad","family":"Movassaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-2958","authenticated-orcid":false,"given":"Hanisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndon","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Hyams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Wenske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiram","family":"Shaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.04.026_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2022.04.026_bib0002","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.juro.2018.04.061","article-title":"Is it time to perform only magnetic resonance imaging targeted cores? Our experience with 1,032 men who underwent prostate biopsy","volume":"200","author":"Pepe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/pcan.2013.43","article-title":"Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard","volume":"17","author":"Abd-Alazeez","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2022.04.026_bib0004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.juro.2014.02.005","article-title":"Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?","volume":"192","author":"Hu","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2013.06.007","article-title":"The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level\u2013can it rule out clinically significant prostate cancer?","volume":"32","author":"Abd-Alazeez","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.04.026_bib0006","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2013.03.025","article-title":"Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen","volume":"65","author":"Sonn","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143404","article-title":"Comparison of multiparametric MRI scoring systems and the impact on cancer detection in patients undergoing MR US fusion guided prostate biopsies","volume":"10","author":"Rastinehad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2022.04.026_bib0008","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.04.057","article-title":"Prospective evaluation of the prostate imaging reporting and data system version 2 for prostate cancer detection","volume":"196","author":"Mertan","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0009","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00345-015-1749-3","article-title":"Can MRI\/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?","volume":"34","author":"Pepe","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/21681805.2017.1281346","article-title":"Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer","volume":"51","author":"von Below","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0011","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cncr.29874","article-title":"Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies","volume":"122","author":"Filson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2022.04.026_bib0012","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.purol.2017.10.001","article-title":"Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?","volume":"28","author":"Albisinni","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0014","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.juro.2018.06.012","article-title":"The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years","volume":"200","author":"Meng","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2022.04.026_bib0016","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2022.04.026_bib0017","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2022.04.026_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1148\/rg.2015140058","article-title":"MR imaging-transrectal US fusion for targeted prostate biopsies: implications for diagnosis and clinical management","volume":"35","author":"Costa","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.urology.2022.04.026_bib0021","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2022.04.026_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.11.006","article-title":"An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-preliminary experience","volume":"35","author":"Costa","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.04.026_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9010225","article-title":"Assessment of the minimal targeted biopsy core number per MRI lesion for improving prostate cancer grading prediction","volume":"9","author":"Ploussard","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.urology.2022.04.026_bib0024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/JU.0000000000000757","article-title":"Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: a systematic review and meta-analysis","volume":"204","author":"Pagniez","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0026","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.urology.2016.11.017","article-title":"The role of ipsilateral and contralateral transrectal ultrasound-guided systematic prostate biopsy in men with unilateral magnetic resonance imaging lesion undergoing magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy","volume":"102","author":"Bryk","year":"2017","journal-title":"Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urolonc.2018.10.009","article-title":"Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy","volume":"37","author":"Freifeld","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.04.026_bib0028","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2019.11.016","article-title":"How many cores should be obtained during saturation biopsy in the era of multiparametric magnetic resonance? experience in 875 patients submitted to repeat prostate biopsy","volume":"137","author":"Pepe","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.04.026_bib0029","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00345-018-2337-0","article-title":"Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?","volume":"37","author":"Gold","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2022.04.026_bib0030","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1007\/s00330-021-07842-9","article-title":"How to improve image quality of DWI of the prostate-enema or catheter preparation?","volume":"31","author":"Reischauer","year":"2021","journal-title":"Eur Radiol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:49:16Z","timestamp":1758768556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S0090429522003491"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.04.026","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}